Centrient Pharmaceuticals Archives | Be Korea-savvy
Centrient Pharmaceuticals Initiates Patent Litigation in India Against Dalas Biotech Limited

Centrient Pharmaceuticals Initiates Patent Litigation in India Against Dalas Biotech Limited

ROTTERDAM, Holland, May 1 (Korea Bizwire) — Centrient Pharmaceuticals announced that on April 25, 2019, its wholly owned subsidiary, Centrient Pharmaceuticals India Private Limited, filed a lawsuit against Dalas Biotech Limited in the High Court of Delhi in New Delhi, India for patent infringement of Indian Patent Number 247301. This patent, which is owned by [...]

The Delhi High Court in India Has Issued an Injunction, Restraining Sinopharm Weiqida from Exporting Its “Amoxycillin Trihydrate” Product to India, as It Infringes the Patent of Centrient Pharmaceuticals

The Delhi High Court in India Has Issued an Injunction, Restraining Sinopharm Weiqida from Exporting Its “Amoxycillin Trihydrate” Product to India, as It Infringes the Patent of Centrient Pharmaceuticals

ROTTERDAM, the Netherlands, Feb. 19 (Korea Bizwire) — Centrient Pharmaceuticals (“Centrient”), the leading manufacturer of beta-lactam antibiotics, and a provider of next generation statins and anti-fungals, announced that the Delhi High Court in India has granted an injunction against Sinopharm Weiqida Pharmaceuticals and Sinopharm India, restricting the export and/or import into India of its active [...]

DSM Sinochem Pharmaceuticals Announces its New Name – Centrient Pharmaceuticals

DSM Sinochem Pharmaceuticals Announces its New Name – Centrient Pharmaceuticals

ROTTERDAM, Netherlands, Dec. 10 (Korea Bizwire) — Effective December 10, 2018 Centrient Pharmaceuticals is the new name for DSM Sinochem Pharmaceuticals, the leading manufacturer of beta-lactam antibiotics and a provider of next-generation statins and anti-fungals. The new name has been chosen to reflect the company’s key contribution to modern healthcare, and marks the next phase [...]